EGFR and colonic neoplasm: We previously reported that the simultaneous blocking of two RTK pathways, i.e., the insulin-like growth factor receptor (IGF-IR) and EGFR pathways, produced more efficient therapeutic effects in colon cancer cell lines than the inhibition of a single pathway [6].